Background: Isolated acute pediatric myocarditis remains a therapeutic challenge, with limited high-quality evidence supporting immunomodulatory therapy. Variability in the use of intravenous immunoglobulin (IVIG) and corticosteroids persists across institutions. This study aimed to assess the knowledge, attitudes, and practices (KAP) of pediatric intensive care unit (PICU) physicians and pediatric cardiologists in Gulf countries, and to explore differences between specialties regarding IVIG and steroid use.
Method: A cross-sectional, anonymous online survey was distributed to PICU physicians and paediatric cardiologists across Gulf countries. The survey assessed physician demographics ,institutional protocols, then it presented a case scenario that assessed physicians knowledge, attitudes and practices regarding the use of IVIG and corticosteroid use in isolated acute paediatric myocarditis.
Results: A total of 201 healthcare professionals from six Gulf countries completed the survey, including 56% PICU physicians and 38 % paediatric cardiologists. Only 17% reported the availability of formal written institutional guidelines. More respondents perceived IVIG to provide meaningful clinical benefit (67%) than corticosteroids (37%), while 47% considered combination therapy more beneficial than monotherapy in severe disease (Figure 1). PICU physicians more frequently perceived benefit from IVIG than paediatric cardiologists (70% and 60%, respectively), whereas cardiologists reported greater perceived benefit from corticosteroids (40 % and 35%). Support for combination therapy was similar between specialties (49 % and 43 %). Initial use of IVIG was reported by 43 % of respondents, while corticosteroid prescribing varied, with 48% not using corticosteroids, 35% using them selectively, and 18% routinely. Notably 95% supported development of standardized national or international guidelines
Conclusion: This multinational survey highlights variability in acute paediatric myocarditis management, with increasing use and a growing perceived role for corticosteroids. IVIG was considered more beneficial, particularly by PICU physicians, underscoring the need for consensus guidelines and prospective multicentre studies.


